{"id":"W2547863170","doi":"10.1182/blood.v104.11.2480.2480","title":"SDX-105 Demonstrates a High Response Rate as a Single-Agent with Acceptable Safety in Rituximab-Refractory, Relpased Indolent or Transformed Non-Hodgkin’s Lymphoma (NHL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Refractory (planetary science); Bendamustine; Gastroenterology; Lymphoma; Follicular lymphoma; Bone marrow; Oncology; Surgery; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008131717,0.0002776124,0.0006787951,0.0002919735,0.0001179824,0.0003670478,0.0002678467,0.0003451948,0.001924129],"category_scores_gemma":[0.0004617346,0.0001363298,0.0003830936,0.0002093271,0.0001825599,0.0002618209,0.0001025047,0.0007879906,0.0005069908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002588,"about_ca_system_score_gemma":0.0001595154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002834747,"about_ca_topic_score_gemma":0.000601528,"domain_scores_codex":[0.9997676,0.0001033453,0.00002098314,0.00003222575,0.00004265076,0.00003323096],"domain_scores_gemma":[0.999711,0.00009277496,0.00004539096,0.00004825202,0.0000179347,0.00008467364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.048053,0.01346953,0.02104411,0.0004209411,0.0005416674,0.001017029,0.000343372,0.002484338,0.4917433,0.000435299,0.004927103,0.4155203],"study_design_scores_gemma":[0.04708786,0.4643913,0.2066855,0.00009286385,0.0005999307,0.006209055,0.0001597448,0.01269135,0.2435602,0.00029743,0.01816314,0.00006172941],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953802,0.001594359,0.001024212,0.0001243332,0.00002936991,0.0001167975,0.0001436577,0.000124039,0.001463037],"genre_scores_gemma":[0.9976495,0.0002805346,0.0007862934,0.00007801985,0.000023323,0.00004258443,0.00045125,0.00001541294,0.000673004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001924129,"threshold_uncertainty_score":0.006436825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01276748807474082,"score_gpt":0.2465276413827582,"score_spread":0.2337601533080174,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}